$CV
CapsoVision, Inc
CIK:0001378325|SEC Filings
CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Income Statement [Abstract] | ||||
| Net revenue | $ 3,643 | $ 3,315 | $ 6,435 | $ 6,098 |
| Costs of revenue | 1,772 | 1,504 | 3,235 | 2,793 |
| Gross profit | 1,871 | 1,811 | 3,200 | 3,305 |
| Selling and marketing | 1,936 | 1,847 | 4,027 | 3,808 |
| Research and development | 5,309 | 3,392 | 9,744 | 6,499 |
| General and administrative | 2,206 | 1,223 | 4,102 | 3,031 |
| Total operating expenses | 9,451 | 6,462 | 17,873 | 13,338 |
| Operating loss | (7,580) | (4,651) | (14,673) | (10,033) |
| Interest income, net | 82 | 37 | 141 | 43 |
| Other non-operating income (expense), net | 17 | (11) | 18 | (10) |
| Total non-operating income, net | 99 | 26 | 159 | 33 |
| Loss before income taxes | (7,481) | (4,625) | (14,514) | (10,000) |
| Provision for income taxes | 0 | 0 | 0 | |
| Net loss | $ (7,481) | $ (4,625) | $ (14,514) | $ (10,000) |
| Net loss per share - basic (in dollars per share) | $ (0.15) | $ (2.02) | $ (0.30) | $ (4.49) |
| Net loss per share - diluted (in dollars per share) | $ (0.15) | $ (2.02) | $ (0.30) | $ (4.49) |
| Weighted-average common shares outstanding - basic (in shares) | 49,937,525 | 2,292,230 | 48,704,069 | 2,225,301 |
| Weighted-average common shares outstanding - diluted (in shares) | 49,937,525 | 2,292,230 | 48,704,069 | 2,225,301 |